Matched Pair Analyses of Stage IV Breast Cancer with or Without Resection of Primary Breast Site
Reports demonstrate improved survival of stage IV breast cancer patients with primary cancer resection. This may result from selection for surgery, rather than biological processes.
We performed matched-pair analysis that minimized potential bias in selecting surgery for primary cancer. Chart review was also performed of 5-year survivors to assess selection bias affecting breast surgery.
19,464 breast cancer patients were identified; 808 (4.2%) were stage IV: 622 were analyzed after eliminating wrong diagnoses or staging, and limiting patients to Massachusetts residents.
Matched-pair analysis narrowed or eliminated apparent survival benefit associated with primary site surgery in several comparisons. When the impact of the sequence of systemic and surgical treatments was studied in stage IV patients, 90% 2-year survival occurred in patients receiving chemotherapy first, in contrast to receiving chemotherapy simultaneously with or after surgery, suggesting selection for delayed surgery after excellent response to initial chemotherapy. In bone metastases, the 2-year survival advantage occurred with chemotherapy before surgery; no difference in survival with or without surgery occurred when these treatments were simultaneous.
Among 5-year survivors, frequency of primary site surgery after excellent response to systemic therapy, breast surgery in stage III patients incorrectly classified as stage IV, and frequency of oligo metastases all indicated selection bias.
Case selection bias in primary breast cancer resection in state IV patients may explain most, if not all, the apparent survival advantage of such surgery.
KeywordsPrimary Breast Cancer Estrogen Receptor Status Male Breast Cancer Complete Clinical Response Supraclavicular Node Metastasis
- 8.Barkley CR, Bafford AC, Burstein HJ, et al. Breast surgery for women presenting with stage IV breast cancer. 5085 Brigham and Women’s Hospital, Boston, MA; Dana Faber Cancer Institute, Boston, MA; Massachusetts General Hospital, Boston, MAGoogle Scholar
- 9.Shien T, Kinoshita T, Shimizu C, et al. Can the resection of primary breast cancer improve survival of patients with stage IV breast cancer? 5086 National Cancer Center Hospital, Tokyo, JapanGoogle Scholar
- 15.AJCC Cancer Staging Manual. In: Greene FK, Page D, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M, eds. 6th edition. New York: Springer-Verlag, 2002Google Scholar
- 16.Chen SC, Chang HK, Lin YC, et al. Prognosis of breast cancer after supraclavicular lymph node metastasis: not a distant metastasis. Ann Surg Oncol 2006 Sep 8; [Epub ahead of print]Google Scholar
- 21.Thelen A, Benckert C, Jonas S, et al. Liver resection for metastases from breast cancer. J Surg Oncol 2007 Nov 27 [Epub ahead of print]Google Scholar
- 23.Rena O, Papalia E, Ruffini E, et al. The role of surgery in the management of solitary pulmonary nodule in breast cancer patients. Eur J Surg Oncol 2007 Jan 29; [Epub ahead of print]Google Scholar
- 24.Yoshimoto M, Tada K, Nishimura S, et al. Favourable long-term results after surgical removal of lung metastases of breast cancer. Breast Cancer Res Treat 2007 Sep 27; [Epub ahead of print]Google Scholar
- 26.Lee SS, Ahn JH, Kim MK, et al. Brain metastases in breast cancer: prognostic factors and management. Breast Cancer Res Treat 2007 Nov 8; [Epub ahead of print]Google Scholar
- 32.Imkampe A, Bendall S, Bates T. The significance of the site of recurrence to subsequent breast cancer survival. EJSO 2006. doi: 10.1016/j.ejso.2006.09.005
- 36.Hortobagyi GN. Can we cure limited metastatic breast cancer? J Clin Oncol 2001;20:620–3Google Scholar